Publication
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00
Journal Paper/Review - Jul 2, 2016
Pruneri Giancarlo, Regan Meredith M, Gelber Richard D, Munzone Elisabetta, Cancello Giuseppe, Price Karen N, Kammler Roswitha, Goldhirsch Aron, Gianni Lorenzo, Ruhstaller Thomas, Láng István, Criscitiello Carmen, Curigliano Giuseppe, Viale Giuseppe, Vingiani Andrea, Gray Kathryn P, Colleoni Marco
Pruneri, Giancarlo
4
0
Gray, Kathryn P
7
0
Vingiani, Andrea
3
0
Viale, Giuseppe
26
0
Curigliano, Giuseppe
3
0
Criscitiello, Carmen
2
0
Láng, István
20
0
Ruhstaller, Thomas
83
24
Gianni, Lorenzo
5
0
Goldhirsch, Aron
51
0
Kammler, Roswitha
11
0
Price, Karen N
43
0
Cancello, Giuseppe
1
0
Munzone, Elisabetta
3
0
Gelber, Richard D
53
0
Regan, Meredith M
37
0
Colleoni, Marco
31
0